1. Home
  2. MPLX vs HLN Comparison

MPLX vs HLN Comparison

Compare MPLX & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MPLX LP

MPLX

MPLX LP

HOLD

Current Price

$52.48

Market Cap

55.0B

Sector

Energy

ML Signal

HOLD

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

HOLD

Current Price

$10.03

Market Cap

44.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPLX
HLN
Founded
2012
2022
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Oil & Gas Production
Package Goods/Cosmetics
Sector
Energy
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
55.0B
44.5B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
MPLX
HLN
Price
$52.48
$10.03
Analyst Decision
Buy
Hold
Analyst Count
7
1
Target Price
$58.83
N/A
AVG Volume (30 Days)
1.4M
8.9M
Earning Date
02-03-2026
02-26-2026
Dividend Yield
8.23%
1.80%
EPS Growth
11.31
41.64
EPS
4.72
0.23
Revenue
$11,632,000,000.00
$15,096,588,575.00
Revenue This Year
$18.15
$1.51
Revenue Next Year
$4.10
$4.67
P/E Ratio
$11.09
$43.94
Revenue Growth
5.53
N/A
52 Week Low
$44.60
$8.71
52 Week High
$56.26
$11.42

Technical Indicators

Market Signals
Indicator
MPLX
HLN
Relative Strength Index (RSI) 41.23 55.70
Support Level $52.88 $9.88
Resistance Level $54.25 $10.31
Average True Range (ATR) 0.96 0.12
MACD -0.26 -0.00
Stochastic Oscillator 33.09 43.88

Price Performance

Historical Comparison
MPLX
HLN

About MPLX MPLX LP

MPLX is a partnership that owns pipelines and gathering and processing assets with extensive holdings in the Appalachian and Permian regions. The asset base is made up of crude oil and refined products assets dropped down from Marathon Petroleum, its sponsor, and natural gas and natural gas liquids gathering and processing assets that were purchased or built.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: